Display search results for ** instead (373 products)
20 Jan 2004  |  North America
The objective of this study is to evaluate the present financial state of the U.S. Healthcare Industry and present financials of top pharmaceutical, biotechnology and medical device companies. The study compares healthcare stocks, investment opportunities, and mergers and acquisitions in different healthcare segments. Movers and Shakers section inc...
USD 1,462.50 save 25 %
01 Dec 2003  |  North America
The objective of this report is to evaluate the present state of the U.S. Tampons Markets and present a forecast and analysis of the revenues, unit shipments and pricing. The forecast period is from 1999 to 2009, with a base year of 2002. The report also identifies the major drivers and restraints, the competitive structure, product analysis, and m...
USD 1,462.50 save 25 %
15 Jun 2009  |  North America
Preparing for an Aging Society: Challenges Faced by Healthcare System in European Union, Japan, and United States
Globally, nations are experiencing a decline in population growth rate accompanied by fall in mortality rate, increase in life expectancy and improvement in health condition. However, these trends have resulted in an increase in percent of aged people in the total population or an Aging Society. The segment gives an overview of the common demogra...
10 Jun 2009  |  North America
Expiring patents on revenue generating drugs, competition from generic drugs and increasing research and development cost, is forcing pharmaceutical manufacturers to often outsource drug discovery processes. Over the years pharmaceutical outsourcing has moved up the value chain from non core functions to even core functions. The segment gives an ov...
29 Jan 2010  |  North America
Amid Stimulus Measures to Bolster the Emerging Economies - What Challenges and Opportunities Lie for the Healthcare Industry?
Though most countries were affected by the current economic slowdown, the impact varied from country to country. The article looks into the affect of slowdown in six emerging countries, namely Brazil, Russia, China, India, Mexico and Poland and covers the highlights of economic stimulus measures adopted by these countries. The article also provides...
14 Jun 2010  |  North America
The global economic slowdown affected almost every nation across the globe, though, the impact varied from country to country. The article discusses the healthcare system, current healthcare related issues and recent health sector initiatives in five developed nations, namely the United States, Japan, Germany, France and United Kingdom. In addition...
26 Jun 2003  |  Asia Pacific
08 Sep 2003  |  Asia Pacific
10 Jul 2003  |  Asia Pacific
07 Nov 2003  |  Asia Pacific
Japan is emerging as a force to reckon with in the global biotechnology landscape. Lately, committed support from the government and resulting administrative changes have brought the Japanese biotech industry to an inflection point. There are plenty of opportunities for Japanese biotech companies to explore and fewer hurdles on their path compared ...